Holen Sie sich die Stockscreener-App
24.85
0.81%
0.19
Schlusskurs vom Vortag:
$24.66
Offen:
$24.36
24-Stunden-Volumen:
122.02K
Relative Volume:
0.25
Marktkapitalisierung:
$1.15B
Einnahmen:
$722.68M
Nettoeinkommen (Verlust:
$134.71M
KGV:
9.3071
EPS:
2.67
Netto-Cashflow:
$109.94M
1W Leistung:
+1.39%
1M Leistung:
-6.72%
6M Leistung:
+1.84%
1J Leistung:
-50.80%
1-Tages-Spanne:
$24.24
$25.13
1-Wochen-Bereich:
$23.77
$25.13
52-Wochen-Spanne:
$20.39
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Firmenname
Amphastar Pharmaceuticals Inc
Sektor
Telefon
909-980-9484
Adresse
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Vergleichen Sie AMPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
24.84 | 1.15B | 722.68M | 134.71M | 109.94M | 2.67 |
|
ZTS
Zoetis Inc
|
142.89 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.42 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.245 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.11 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
447.46 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-12 | Hochstufung | Needham | Hold → Buy |
| 2025-05-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-02-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-03-05 | Eingeleitet | JP Morgan | Overweight |
| 2023-11-17 | Eingeleitet | BofA Securities | Neutral |
| 2023-07-25 | Fortgesetzt | Jefferies | Buy |
| 2022-10-21 | Fortgesetzt | Jefferies | Buy |
| 2022-07-29 | Eingeleitet | CapitalOne | Overweight |
| 2022-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | Eingeleitet | Northland Capital | Outperform |
| 2019-03-13 | Herabstufung | Needham | Buy → Hold |
| 2019-03-13 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | Bestätigt | Needham | Buy |
| 2018-03-13 | Bestätigt | Needham | Buy |
| 2017-12-01 | Bestätigt | Needham | Buy |
| 2017-11-09 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | Bestätigt | Needham | Buy |
| 2017-03-14 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | Bestätigt | Needham | Buy |
| 2016-05-10 | Bestätigt | Needham | Buy |
| 2016-02-19 | Eingeleitet | Wells Fargo | Outperform |
| 2015-06-19 | Bestätigt | Needham | Buy |
| 2015-06-03 | Eingeleitet | Raymond James | Strong Buy |
| 2014-07-21 | Eingeleitet | Needham | Buy |
Alle ansehen
Amphastar Pharmaceuticals Inc Aktie (AMPH) Neueste Nachrichten
Will Amphastar Pharmaceuticals Inc. stock deliver shareholder valueJuly 2025 Retail & Capital Efficiency Focused Ideas - newser.com
Real time scanner hits for Amphastar Pharmaceuticals Inc. explainedWeekly Market Report & AI Forecasted Entry/Exit Points - newser.com
Why Amphastar Pharmaceuticals Inc. (29A) stock could be next leader2025 Investor Takeaways & Short-Term Trading Alerts - newser.com
Analyzing recovery setups for Amphastar Pharmaceuticals Inc. investorsJuly 2025 Price Swings & Free Expert Approved Momentum Trade Ideas - newser.com
Using Python tools to backtest Amphastar Pharmaceuticals Inc. strategiesInsider Selling & Real-Time Stock Movement Alerts - newser.com
Will Amphastar Pharmaceuticals Inc. (29A) stock outperform energy sector in 2025July 2025 Decliners & Target Return Focused Picks - newser.com
Can trapped investors hope for a rebound in Amphastar Pharmaceuticals Inc.Portfolio Update Summary & Reliable Intraday Trade Plans - newser.com
Can Amphastar Pharmaceuticals Inc. stock maintain growth trajectoryQuarterly Market Summary & Free High Accuracy Swing Entry Alerts - newser.com
Should you wait for a breakout in Amphastar Pharmaceuticals Inc.2025 Stock Rankings & Daily Entry Point Trade Alerts - newser.com
Can Amphastar Pharmaceuticals Inc. stock hit analyst price targetsProduct Launch & Fast Entry Momentum Alerts - newser.com
Key metrics from Amphastar Pharmaceuticals Inc.’s quarterly data2025 Analyst Calls & Fast Moving Market Watchlists - newser.com
Why Amphastar Pharmaceuticals Inc. stock remains resilientJuly 2025 Institutional & Real-Time Chart Pattern Alerts - newser.com
How Amphastar’s New BAQSIMI Distribution Pact in Greater China Could Impact AMPH Investors - Yahoo Finance
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Is Amphastar Pharmaceuticals Inc. (29A) stock trading at attractive multiplesJuly 2025 Catalysts & Community Verified Swing Trade Signals - newser.com
What momentum shifts mean for Amphastar Pharmaceuticals Inc.Weekly Profit Summary & AI Optimized Trade Strategies - newser.com
Multi asset correlation models including Amphastar Pharmaceuticals Inc.Dollar Strength & Weekly Top Performers Watchlists - newser.com
Is Amphastar Pharmaceuticals Inc. (29A) stock a buy for dividend portfoliosPortfolio Return Report & Low Risk High Win Rate Picks - newser.com
United States Anaphylaxis Treatment Market 2025: Industry - openPR.com
Applying Elliott Wave Theory to Amphastar Pharmaceuticals Inc.July 2025 Earnings & Precise Buy Zone Identification - newser.com
Why Amphastar Pharmaceuticals Inc. stock attracts high net worth investorsWatch List & Safe Entry Trade Reports - Fundação Cultural do Pará
Amphastar Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
AlphaQuest LLC Acquires 17,289 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Will Amphastar Pharmaceuticals Inc. (29A) stock beat international competitionWeekly Loss Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Finanzdaten der Amphastar Pharmaceuticals Inc-Aktie (AMPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
6.04%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):